|
End-of-day quote
Berne S.E.
2026-09-04
|
5-day change | 1st Jan Change | ||
| 135.15 CHF | +2.81% |
|
+2.20% | -6.70% |
| 06:26pm | AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah | MT |
| Sep. 04 | FDA Approves AstraZeneca Treatment for Advanced Breast Cancer -- Update | DJ |
| Market Cap | 252B 217B 204B 186B 348B 23,773B 349B 2,409B 935B 12,197B 945B 925B 39,293B | P/E 2026 * |
20.9x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 271B 233B 220B 201B 375B 25,610B 376B 2,595B 1,007B 13,140B 1,019B 996B 42,330B | EV / Sales 2026 * |
4.29x | EV / Sales 2027 * | 3.94x |
| Free-Float |
96.63% | Yield 2026 * |
2.06% | Yield 2027 * | 2.19% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Berne S.E.
| 000982352 | End-of-day quote | |
|
Mexican S.E.
| AZN1 N | End-of-day quote |
Last Transcript : AstraZeneca PLC
| 1 day | +2.81% | ||
| 1 week | +2.20% | ||
| Current month | +1.84% | ||
| 1 month | +4.29% | ||
| 3 months | -4.96% | ||
| 6 months | -13.17% | ||
| Current year | -6.70% |
| 1 week | 131.45 |  | 135.15 |
| 1 month | 126.7 | | 135.15 |
| Current year | 124.91 | | 163 |
| 1 year | 116.75 | | 163 |
| 3 years | 104.86 | | 163 |
| 5 years | 95 | | 163 |
| 10 years | 52.7 | | 163 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 2012-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 2021-07-31 |
Jeffrey Pott
CMP | Compliance Officer | - | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 1999-04-05 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 2012-09-30 |
Philip Broadley
BRD | Director/Board Member | 65 | 2017-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.81% | +2.20% | - | - | 255B | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,034B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 671B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 188B | |
| Average | -0.61% | +1.10% | +28.30% | +51.13% | 412.97B | |
| Weighted average by Cap. | -0.85% | +0.51% | +36.62% | +66.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.25B 54.43B 51.21B 46.78B 87.51B 5,972B 87.74B 605B 235B 3,064B 238B 232B 9,870B | 66.85B 57.53B 54.12B 49.44B 92.49B 6,312B 92.75B 640B 248B 3,238B 251B 246B 10,433B |
| Net income | 12.02B 10.34B 9.73B 8.89B 16.63B 1,135B 16.67B 115B 44.62B 582B 45.13B 44.14B 1,875B | 13.7B 11.79B 11.09B 10.13B 18.96B 1,294B 19.01B 131B 50.86B 664B 51.45B 50.33B 2,138B |
| Net Debt | 19.46B 16.75B 15.76B 14.39B 26.93B 1,838B 27B 186B 72.25B 943B 73.08B 71.49B 3,037B | 11.79B 10.14B 9.54B 8.72B 16.31B 1,113B 16.35B 113B 43.76B 571B 44.27B 43.3B 1,840B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | CHF 135.15 | +2.81% | 45 |
| 26-09-02 | CHF 131.45 | -0.95% | 24 |
| 26-08-31 | CHF 132.71 | +0.36% | 41 |
| 26-08-28 | CHF 132.24 | +0.75% | 1 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- 000982352 Stock
Select your edition
All financial news and data tailored to specific country editions
